The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1320
ISSUE1320
September 7, 2009
Prasugrel (Effient) vs. Clopidogrel (Plavix)
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Prasugrel (Effient) vs. Clopidogrel (Plavix)
September 7, 2009 (Issue: 1320)
The FDA has approved prasugrel (Effient - Lilly/Daiichi Sankyo), an oral antiplatelet drug, for use with aspirin to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndromes (ACS) being managed with percutaneous...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.